HOME >> BIOLOGY >> NEWS
NYU researchers find that genetically engineered corn releases insecticidal toxin into soil

Researchers at New York University have found that insect-killing toxin from Bt corn is released into soil from the roots. The scientists say more research is needed to determine whether this exuded toxin has a good, bad, or neutral effect on organisms in soil.

The research was conducted by NYU biology professor Guenther Stotzky, NYU research scientist Deepak Saxena, and Saul Flores of the Venezuelan Scientific Research Institute. The team's findings were published in the December 2nd issue of Nature in a brief communication entitled, "Insecticidal toxin in root exudates from Bt corn."

Bt corn is corn that has been genetically modified to produce an insecticidal toxin derived from the bacterium, Bacillus thuringiensis (Bt). The toxin is present in the plant's tissues and kills the larvae of caterpillars that attack the plant. It was previously believed that the Bt toxin molecule was too large to be released through the plant's root system. Recently it was shown that the toxin is also present in the pollen of Bt corn and that when the pollen was placed on the leaves of milkweed, it killed monarch butterflies that ate the contaminated leaves.

Professor Stotzky said, "We have no indication of how soil communities might be affected by the Bt toxin that these plants exude. It might improve control of insect pests. It might enhance the rate at which insect pests become resistant to the toxin. It might negatively impact beneficial insects. These are troubling questions, and we don't know the answers yet."

About 15 million acres of Bt corn were planted the U.S. in 1998, which was just under 20% of the nation's total corn acreage.

The researchers grew Bt corn in a plant-growth room and then collected samples of root exudates from the roots and from nearby soil. They found that active Bt toxin was exuded by the roots throughout the growth of the plants, and that the toxin, which binds on soil, retained the abili
'"/>

Contact: Josh Plaut
JOSH.PLAUT@NYU.EDU
212-998-6797
New York University
12-Dec-1999


Page: 1 2

Related biology news :

1. Belgian researchers explore revolutionary approach to angiogenesis
2. Award winning researchers reveal potential new role for Glivec
3. $7.5 Million grant to Yale researchers for role of viruses in cancer
4. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
5. Joslin researchers clarify mechanisms for beta-cell formation
6. Virginia Tech researchers to release findings on Smith River Project
7. Molecular motor myosin VI moves hand over hand, researchers say
8. ASU researchers demonstrate new technique that improves the power of atomic force micrscopy
9. Emory researchers map structure of anti-cancer molecule
10. Leukemia stem cells identified by Stanford researchers
11. EURYI Award given for the first time to 25 young European researchers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
(Date:6/28/2020)... Fla. (PRWEB) , ... June 25, 2020 , ... In ... focus on innovations in accelerated Point of Care Testing solutions (POCT). Check local listings ... Samples are collected at medical offices and are shipped to labs throughout the country. ...
(Date:6/23/2020)... ... 23, 2020 , ... Rigaku Corporation , a global ... a series of TOPIQ webinars, which will cover the Transferable Aspherical Atom Model ... response to social distancing measures that resulted in postponements and cancelations of global ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 17, 2020 , ... ... firm for the life sciences and food industries, is pleased to announce that ... Clinical Research – Business Development. , Charles is an accomplished and results-driven sales ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... Technology (MIT) has expanded the company’s exclusive license to include clinical applications ... point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast ...
(Date:7/10/2020)... , ... July 09, 2020 , ... ... cell therapy, today announced the hiring of Allen R. Nissenson, M.D., F.A.C.P., as ... oversee the clinical development of Sentien’s lead product, SBI-101. Dr. Nissenson serves ...
(Date:7/7/2020)... , ... July 06, 2020 , ... ... Awards. Entries from Roche, Eli Lilly, Bristol-Myers Squibb, the University of Chicago, Massachusetts ... Bio-IT World has hosted an elite awards program, highlighting outstanding examples of how ...
Breaking Biology Technology:
Cached News: